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Summary The association between functioning of the hypothalamic pituitary adrenal (HPA)
axis and physical performance at older ages remains poorly understood. We carried out meta-
analyses to test the hypothesis that dysregulation of the HPA axis, as indexed by patterns of
diurnal cortisol release, is associated with worse physical performance. Data from six adult
cohorts (ages 50—92 years) were included in a two stage meta-analysis of individual participant
data. We analysed each study separately using linear and logistic regression models and then used
meta-analytic methods to pool the results. Physical performance outcome measures were
walking speed, balance time, chair rise time and grip strength. Exposure measures were morning
(serum and salivary) and evening (salivary) cortisol. Total sample sizes in meta-analyses ranged
from n = 2146 for associations between morning Cortisol Awakening Response and balance to
n = 8448 for associations between morning cortisol and walking speed. A larger diurnal drop was
associated with faster walking speed (standardised coefficient per SD increase 0.052, 95%
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1. Introduction
The hypothalamic pituitary adrenal (HPA) axis is one of
several plausible candidate pathways contributing to bio-
logical ageing. It activates the secretion of glucocorticoids
(cortisol in man) in response to stressful stimuli and exhi-
bits a marked circadian rhythm so that in humans cortisol
levels are higher in the morning and decline over the day. A
recent report from the Whitehall II (WHII) cohort found that
older individuals do have a flatter diurnal pattern (Kumari
et al., 2010), a risk factor for age-related chronic condi-
tions, such as cardiovascular disease (Kumari et al., 2011).
In the Longitudinal Aging Study Amsterdam (LASA), higher
morning and night time cortisol was associated with mor-
tality (Schoorlemmer et al., 2009). Furthermore, a flatter
diurnal pattern in older individuals has been associated
with poorer cognitive function (O’Hara et al., 2007;
Beluche et al., 2010).
Walking speed, standing balance, chair rise time and grip
strength are simple, objective measures of physical perfor-
mance (Birnie et al., 2011; Cooper et al., 2011b). In older
populations, sarcopenia (i.e., the loss of muscle mass and
strength) (Abellan Van Kan, 2009; Cruz-Jentoft et al., 2010)
may develop and there is reduced physical performance,
which predicts disability (Guralnik et al., 1995), hospital
admissions (Penninx et al., 2000) and mortality (Cooper
et al., 2010). The extent to which poor physical perfor-
mance is linked to age-related changes in regulation of the
HPA axis is not well known, but long-term exposure to high
cortisol levels, a potent stimulus to protein catabolism, has
been postulated as a potential mechanism for sarcopenia
(Marcell, 2003). At least three population based studies
have reported associations between cortisol levels and
physical performance tests (Peeters et al., 2007, 2008;
Kumari et al., 2010; Gardner et al., 2011). In the WHII study
(Kumari et al., 2010) and Caerphilly Prospective Study
(CaPS) (Gardner et al., 2011) individuals with less diurnal
variability had slower walking speed, whilst in LASA there
were gender differences so that women with higher cortisol
levels showed worse performance on a standing balance test
and men with higher cortisol levels were slower in walking
and chair rises (Peeters et al., 2007). In a longitudinal
analysis of LASA, higher cortisol was additionally associated
with higher risk of a loss of grip strength over four-years
(Peeters et al., 2008).
We have undertaken an individual participant data (IPD)
meta-analysis (Riley et al., 2010) from six cohorts, including
new unpublished data, as part of the Healthy Ageing across
the Life Course (HALCyon) programme, to assess the associa-
tions between various measures of cortisol and a range of
physical performance tests. This approach has several major
advantages: (a) greater statistical power to test for modest
associations and sub-group interactions; (b) standardising
analyses by grouping covariates in the same way across
studies; (c) multiple measures of both cortisol and physical
performance allowing a detailed characterisation of the
association. We hypothesised that lack of diurnal decline
and hence higher cortisol levels across the day would be
associated with worse physical performance as this reflects
dysregulation of the HPA axis.
2. Methods
2.1. The cohorts
The Healthy Ageing across the Life Course (HALCyon)
research programme is a cross-cohort study on ageing. Of
the nine UK cohort studies involved in HALCyon, four have
data on both cortisol and physical performance: the Boyd Orr
cohort (Martin et al., 2005); the Caerphilly Prospective Study
(CaPS) (Smith et al., 2005); the Hertfordshire Cohort Study
(HCS) (Syddall et al., 2005); and the MRC National Survey of
Health and Development (NSHD) (Wadsworth et al., 2006;
Kuh et al., 2011). To increase scientific value (for example
enhancing the sample size for individual participant data
meta-analysis) we have additionally collaborated with two-
large scale cohort studies: the Longitudinal Ageing Study
Amsterdam (LASA) (Huisman et al., 2011); and the Whitehall
II (WHII) study (Marmot and Brunner, 2005). Details of the
cohorts are given in Supplementary Data 1.
2.2. Physical performance measures
2.2.1. Chair rises
Chair rising ability was assessed in HCS, LASA and NSHD. In
HCS (59—73 years) LASA serum (64—88 years) and LASA
salivary (63—92 years), the time taken for participants to
stand up from a chair and sit down five consecutive times as
fast as possible, was recorded. In NSHD (60—64 years), the
same test was undertaken but 10 rises were performed.
2.2.2. Grip strength
Grip strength was assessed in HCS (59—73 years), LASA
serum (64—88 years), LASA salivary (63—92 years) and NSHD
(age 60—64 years). Dynamometers were used to record
either two (LASA) or three (HCS and NSHD) measures in
each hand. In HCS and NSHD, maximum grip strength (kg)
achieved was used in the main analyses and in LASA grip
strength was calculated as the mean of the maximum scores
of the left and right hand (kg), as previously published
(Peeters et al., 2008).
confidence interval (CI) 0.029, 0.076, p < 0.001; age and gender adjusted) and a quicker chair rise
time (standardised coefficient per SD increase 0.075, 95% CI 0.116, 0.034, p < 0.001; age and
gender adjusted). There was little evidence of associations with balance or grip strength. Greater
diurnal decline of the HPA axis is associated with better physical performance in later life. This
may reflect a causal effect of the HPA axis on performance or that other ageing-related factors are
associated with both reduced HPA reactivity and performance.
# 2012 Elsevier Ltd. 
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2.2.3. Standing balance
Standing balance was assessed in Boyd Orr (63—83 years),
CaPS (65—83 years), HCS (59—73 years), LASA serum (64—88
years), LASA salivary (63—92 years) and NSHD (age 60—64
years). In Boyd Orr, CaPS, HCS and NSHD, the longest time up
to 30 s that a one-legged stand could be maintained with eyes
open was recorded. In LASA, the participant stood with one
foot behind the other (heel against toe) for 10 s. Two trials
were performed in Boyd Orr and CaPS (best values used) and
one trial in the other cohorts.
2.2.4. Walking speed
In Boyd Orr (63—83 years), CaPS (65—83 years), HCS (59—73
years) and NSHD (age 60—64 years) the time to get up from a
chair, walk 3 m at normal speed, turn around, walking back
and sitting down was recorded (timed get up and go) (Pod-
siadlo and Richardson, 1991). In LASA serum and LASA sali-
vary, the participant walked 3 m along a line, turned around
and walked back as fast as possible without running. In WHII
(50—73 years), participants walked at a normal pace over a
clearly marked 2.4 m course using a standardised protocol
(Guralnik et al., 1994) and the time recorded. In LASA, HCS
and NSHD one trial was performed, in Boyd Orr and CaPS two
trials were performed (average values used) and in WHII
three trials were performed (average values used).
2.2.5. Harmonisation of measures
To take account of differences in the protocols used to assess
each of the physical performance measures in the different
cohorts, the measures were harmonised. Details of the work
undertaken to harmonise the measures are provided else-
where (Cooper et al., 2011a). Firstly, we transformed (loge)
chair rise times as they were positively skewed. To take
account of differences in distances walked in different
cohorts we converted walking times into walking speed
(metres per minute). In each of the cohorts, balance time
was dichotomised at the bottom 20th centile and those in this
group were classified as poor balance compared to the rest of
the sample. For the purposes of the main analyses, all the
outcome measures, with the exception of balance time which
had been converted to a binary variable, were then standar-
dised by computing study-specific z-scores to further take
account of protocol variability.
2.3. Cortisol measures
Fasting morning serum cortisol samples were taken, frozen
and subsequently measured by radioimmunoassay (Riad-
Fahmy et al., 1979) in Boyd Orr (63—83 years) and HCS
(59—73 years). In LASA, morning serum cortisol samples were
taken at age 64—88 years and the serum levels of cortisol
were determined using a competitive immunoassay (Peeters
et al., 2007). Both the inter-assay and intra-assay coeffi-
cients of variation ranged from 6% in LASA (Peeters et al.,
2007) to 8% in HCS.
Salivary cortisol samples were collected in CaPS (65—83
years), NSHD (age 60—64 years), LASA (63—92 years) and
WHII (50—73 years). Participants were shown how to collect
saliva using plain cotton wool swabs (salivettes) at home.
Subjects were requested to chew on the salivettes for 1—
2 min and a saliva sample was obtained. In CaPS participants
took samples on waking, 30 min later, at 2 pm and 10 pm on
two consecutive days. In LASA samples were taken 30 min
after waking and at approximately 11 pm. In NSHD samples
were taken on waking, 30 min later and at 9 pm. An addi-
tional sample was taken at the clinic visit around mid-
morning but has not been used in this analysis. In WHII,
samples were taken on waking, at waking + 30 min, +2.5 h,
+8 h, +12 h and at bedtime. Samples were frozen and sub-
sequently assayed by radioimmunoassay. In CaPS, NSHD and
WHII morning salivary cortisol was computed as the mean of
waking and 30 min samples. In CaPS, NSHD and WHII assays
were done in the same laboratory (Dresden) specialising in
high through-put cortisol assays (Kirschbaum and Hellham-
mer, 1989). In LASA, radioimmunoassay coated tubes (Spec-
tria Orion Diagnostics, Turku, Finland) were used to
determine morning and evening salivary cortisol. The
inter-assay coefficient of variation for the salivary cortisols
ranged from 4% in CaPS at both low (5.3 nmol/l) and high
(39.0 nmol/l) controls (Smith et al., 2005) to less than 19% in
LASA (Peeters et al., 2007).
2.4. Clinical and questionnaire-based data
Anthropometric measures were taken at clinic (Boyd Orr,
CaPS, HCS, NSHD and WHII) or by medical interview at home
(LASA). Standing height was measured to the nearest mm
using a stadiometer (CaPS, HCS, LASA, NSHD and WHII) or a
portable measuring stand (Boyd Orr). Weight was measured
in kg using a W&T Avery standard model calibrated balance
(Boyd Orr), using standardised scales (CaPS and NSHD), a
SECA floor scale (HCS and LASA) or by an electronic Soehule
scale (Leifheit AS) with a digital readout (WHII). Body Mass
Index (BMI) was calculated as weight divided by height2 (kg/
m2). Smoking behaviour was assessed by self-completed
questionnaire (Boyd Orr, CaPS and WHII) or medical interview
(HCS, LASA and NSHD). The derived variable for smoking
status was classified into never, past or current.
2.5. Statistics
2.5.1. Missing data
Of those who attended clinic, the percentage with measures
of both physical performance and cortisol (physical perfor-
mance measure given with maximum number of participants
when more than one test) was 71% in Boyd Orr, 76% in CaPS,
72% in HCS, 83% in LASA serum, 75% in LASA salivary, 70% in
NSHD and 48% in Whitehall II (see Table 1 for sample sizes). In
NSHD, salivary cortisol measures were added in the second
stage of the data collection, which explains why the numbers
are lower than the numbers attending clinic. In Whitehall II,
of the 6484 participants who had a clinical assessment, only
4967 were asked to provide a cortisol sample. The lower
percentage in Whitehall II was because 1002 cortisol samples
were not assayed due to loss of sample in transport between
London and Germany or insufficient saliva. This loss of data is
likely to be random and not associated with any of the
participant characteristics. Those participants excluded
due to taking oral corticosteroids are given in Table 1. Only
the Whitehall II study was able to exclude morning samples
that were not taken within 10 min of waking (Kumari et al.,
2010) and the 48% of participants in Whitehall II with both
42 M.P. Gardner et al.
physical performance and cortisol measures are for those
that collected samples within 10 min of waking.
2.5.2. Initial treatment of the data and
standardisation
Cortisol has a marked circadian rhythm and therefore the
time of day at which cortisol is sampled may affect the
cortisol level. In CaPS, NSHD and WHII, data on the actual
times at which salivary cortisol samples were taken were
available. We therefore adjusted the observed values for the
time of sampling by fitting a linear or polynomial function to
the association between cortisol and time of measurement.
In case actual time of sampling predicted cortisol levels, we
added residuals from the best fit model to the overall mean
cortisol value (Smith et al., 2005). In addition to the morning
and night time values, we derived the diurnal drop (differ-
ence between morning and evening salivary cortisol sam-
ples) and the ‘Cortisol Awakening Response’ (CAR)
(difference between the 30 min post waking sample and
the waking sample), measures commonly used in epidemio-
logical studies (Adam and Kumari, 2009). In WHII we
excluded participants who took samples later than 10 min
after waking.
We used linear regression models to analyse chair rise
times, grip strength and walking speed and logistic regression
analysis for balancing ability. Serum cortisol levels represent
total protein bound and free cortisol concentrations in the
blood and are around 20 times higher than the free cortisol
concentrations found in saliva. A study on the relationship
between serum and salivary cortisol in healthy individuals
(Reid et al., 1992), showed that correlations were high
whether taken at the same time (>0.90) or 70 min apart
(0.54—0.94). We therefore converted the absolute levels to
study- specific z-scores (mean = 0, standard deviation = 1) by
dividing the difference between the observed value and the
mean by the standard deviation. As night time cortisol was
positively skewed, we transformed it (loge) before converting
it to a z-score. We chose potential confounders for the
analysis from the literature (age (Larsson et al., 2009), sex
(Larsson et al., 2009), adiposity (Larsson et al., 2009) and
smoking status (Badrick et al., 2007)) and adjusted the final
multivariable model for age (as a continuous term and in
quartiles to examine for departure from linearity), sex, Body
Mass Index (BMI) (kg/m2) and smoking status (never, past or
current smoker) at the same time as the cortisol assay.
2.5.3. Analysis
We performed a two stage meta-analysis of individual parti-
cipant data with each model initially ran within each cohort
(the first stage). The cohort-specific effect estimates and
Table 1 Characteristics of the participants aged 50—94 years by study.
Variable Boyd Orr CaPS HCS LASA
serum
LASA
salivary
NSHD Whitehall II
Clinic attendeesa 405 1197 2997 1509 1474 2229 6484
Sample with cortisol and
physical performance
286 911 2162 1247 1098 1566 3098
Gender (% male) 44.4 100 34.1 52.0 49.5 46.5 74.8
Age (years) 70.5 (4.2) 73.1 (4.0) 67.6 (2.6) 74.0 (6.1) 73.6 (6.5) 63 61.1 (5.9)
Age range at clinic (years) 63—83 65—83 59—73 64—88 63—92 60—64 50—73
BMI (kg/m2) 27.4 (4.4) 27.8 (3.8) 27.2 (4.3) 26.7 (3.9) 27.1 (4.1) 27.7 (4.6) 26.7 (4.3)
Smoking status (% yes) 9.8 13.3 9.6 19.3 15.2 14.9 7.9
Serum cortisol (nmol/L) 442.2
(128.9)
— 254.2
(83.8)
491.6
(168.7)
— — —
Salivary cortisol (nmol/L)
Morning — 19.8 (10.3) — — 15.8 (8.0) 23.3 (9.3) 20.0 (8.2)
Night time — 3.6 (5.2) — — 3.9 (4.6) 3.3 (3.8) 2.4 (2.7)
Walk speedb (m/min) 39.2 (8.6) 35.6 (7.6) 34.4 (5.5) 51.3 (14.9) 48.7 (14.5) 42.2 (9.2) 74.1 (15.9)
Standing balancec (s) 17.6
(6.4—30)
15.7
(4.8—30)
19.2
(7.5—30)
10.0 10.0 30.0
(12.3—30)
—
Cut-point (bottom 20%) (s) 4.9 3.7 5.6 9.0 9.0 9.1 —
Chair rise time (s) — — 17.4 (4.9) 12.9 (4.5) 12.7 (4.7) 24.8 (7.3) —
Grip strength (kg)
Males — — 44.6 (7.5) 37.1 (7.2) 35.9 (9.0) 45.9 (10.9) —
Females — — 26.4 (5.6) 22.2 (4.7) 22.1 (6.3) 27.0 (7.3) —
Exclusions due to oral
corticosteroids (%)
0 1.2 0.8 2.1 2.7 0 5.1
a Sample with cortisol and physical performance is the maximum sample size. Results are presented as mean (SD), unless otherwise stated
and are based on complete case analysis.
b Walk speed in Boyd Orr, CaPS, NSHD and HCS is the get up and go test. In LASA participant walks 3 m, turns and a further 3 m and in
Whitehall II it is a 2.4 m walk. Walk speed was at a normal pace in Boyd Orr, CaPS, HCS, NSHD and Whitehall II and at a fast pace in LASA.
c Standing balance in Boyd Orr, CaPS, HCS and NSHD is a one-legged stand for 30 s, whereas in LASA it is a tandem stand for 10 s. Median
balance times (and inter-quartile range) and cut-point times for bottom 20% are given. There is a ceiling effect for the tandem balance in
LASA, hence inter-quartile range is not given.
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Table 2 Overall summary estimates of effect for the associations between cortisol measures and physical performance from fixed or random effects meta-analyses.
Outcome and
cortisol measure
Model A (age, sex adjusted) Model B (age, sex, BMI and smoking status adjusted)
ESy 95% CI p-Value I 2 p-Valuez ESy 95% CI p-Value I 2 p-Valuez
Walking speed (sd score)
Morning (n = 8448) 0.027 0.007, 0.048 0.008 0.0% 0.97 0.011 0.009, 0.031 0.28 0.0% 0.51
Night time (n = 6234) 0.070 0.113, 0.027 0.001 63.6% 0.041 0.062 0.116, 0.007 0.027 78.5% 0.003
Diurnal dropa (n = 6063) 0.052 0.029, 0.076 < 0.001 0.0% 0.79 0.041 0.017, 0.064 0.001 0.0% 0.50
CARb (n = 5118) 0.028 0.002, 0.054 0.037 0.0% 0.87 0.031 0.005, 0.057 0.021 0.0% 0.88
Chair rises (sd score)
Morning (n = 3441) 0.037 0.07, 0.004 0.027 0.0% 0.72 0.014 0.047, 0.018 0.38 1.0% 0.36
Night time (n = 2307) 0.045 0.005, 0.085 0.027 0.0% 0.75 0.032 0.007, 0.072 0.11 0.0% 0.35
Diurnal dropa (n = 2169) 0.075 0.116, 0.034 < 0.001 0.0% 0.48 0.053 0.094, 0.013 0.01 23.3% 0.25
CARb (n = 1231) 0.015 0.071, 0.040 0.59 0.019 0.073, 0.035 0.48
Odds of poor balance
Morning (n = 4570) 1.05 0.94, 1.16 0.41 35.6% 0.18 1.08 1.0, 1.18 0.06 0.0% 0.55
Night time (n = 3134) 1.14 1.04, 1.26 0.008 2.8% 0.36 1.12 1.01, 1.24 0.04 32.3% 0.23
Diurnal dropa (n = 2985) 1.03 0.89, 1.19 0.69 39.5% 0.19 1.05 0.94, 1.18 0.36 0.0% 0.57
CARb (n = 2146) 1.03 0.92, 1.15 0.59 0.0% 0.90 1.01 0.90, 1.14 0.85 0.0% 0.85
Grip strength (kg)
Morning (n = 4781) 0.056 0.266, 0.154 0.60 0.0% 0.54 0.051 0.264, 0.161 0.64 0.0% 0.41
Night time (n = 2382) 0.274 0.834, 0.285 0.34 63.1% 0.10 0.086 0.757, 0.585 0.80 72.8% 0.06
Diurnal dropa (=2240) 0.117 0.224, 0.458 0.50 0.0% 0.60 0.052 0.296, 0.399 0.77 54.6% 0.14
CARb (n = 1224) 0.207 0.338, 0.752 0.46 0.154 0.401, 0.708 0.59
n = sample size in age and sex adjusted analyses.
a Diurnal drop is the difference between morning and night time salivary cortisol.
b CAR is the difference between the 30 min post waking sample and the waking sample — for chair rises and grip strength this is only for NSHD.All cortisol measures have been z-scored. Random
effects meta-analyses were for I2  35.6%, otherwise fixed effect meta-analyses were used.
y Mean difference in standardised walking speed; mean differences in standardised chair rise time (loge); Odds Ratio of poor balance (lowest 20%); mean difference in grip strength.
z p-Value is obtained from the heterogeneity x2.
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standard errors were then pooled using meta-analysis (the
second stage). We used fixed effects meta-analysis with the
Mantel—Haenszel method except in the presence of signifi-
cant heterogeneity (I2  35.6%) when random-effects models
with the DerSimonian and Laird method were used. These
analyses adjusted initially for age and sex and then addi-
tionally for BMI and smoking status. We examined potential
interactions by running sub-group analyses for sex, age group
(above versus below the median age) and adiposity (BMI
at 30 kg/m2 versus <30 kg/m2 for obese and non-obese
participants). The rationale for these subgroup analysis
was that sex differences have been observed previously in
LASA, healthy survivor bias may operate in particularly at
older ages, and that obese participants may have impaired
cortisone (inactive) to cortisol (active) conversion (Stewart
et al., 1999).
We undertook a series of sensitivity analyses using: (a) the
30 min post-waking rather than mean morning cortisol level,
(b) salivary or serum cortisol from LASA, (c) less than 5 s as
the criteria for poor balance, (d) maximum grip strength for
Overall (I -squared =  0.0%, p = 0.974)
LASA
HCS
BoydOrr
Study
WhitehallII
CaPS
NSHD
B
B
B
Sex
B
M
B
74
68
71
Age
61
73
63
Salivary
Serum
Serum
Cortisol
Salivary
Salivary
Salivary
0.03 (0.01, 0.05)
0.04 (-0.01, 0.10)
0.02 (-0.03, 0.06)
0.02 (-0.09, 0.13)
ES (95% CI)
0.03 (-0.00, 0.06)
0.01 (-0.05, 0.08)
0.03 (-0.02, 0.08)
100.00
14.30
16.74
%
3.40
Weight
38.42
10.37
16.76
worse performance better performance 
-.129 0 .129
Differences in standardised walk speed per SD increase in cortisol adjusted for age and se x
Morning cortisol and walk speed
Overall  (I-squared = 0.0%, p = 0.790)
Whitehall II
CaPS
NSHD
Study
LASA
B
M
B
Sex
B
61
73
63
Age
74
Salivary
Salivary
Salivary
Cortisol
Salivary
0.05 (0.03, 0.08)
0.05 (0.02, 0.08)
0.05 (-0.01, 0.11)
0.04 (-0.01, 0.09)
ES (95% CI)
0.08 (0.02, 0.14)
100.00
49.23
14.03
19.70
%
Weight
17.03
worse performance better performance 
-.135 0 .135
Difference in standardised walk sp eed per SD increase in diurnal drop adjusted for age and se x
Diurnal drop and walk speed
a
b
Figure 1 (A) Meta-analysis of the association between morning cortisol and walking speed adjusted for age and gender. (B) Meta-
analysis of the association between diurnal drop and walking speed adjusted for age and gender.
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the LASA cohort (e) inclusion of subjects with no data due to
inability to undertake the test and (f) for HCS using the 3 m
walk test rather than the TUG test for walking speed (see
Supplementary Data 2).
3. Results
Descriptive characteristics of the participants in the six
studies are shown in Table 1. Age range was from 50 to 92
years, the youngest cohort being WHII, mean age
61.1  5.9 SD years and the oldest LASA, mean age
74.0  6.1 SD years. Mean walking speed and chair rise times
varied considerably between the studies, in part due to
differences in tests carried out. Mean chair rise time ranged
from 12.7  4.7 SD s for five chair rises in LASA to
24.8  7.3 SD s for ten chair rises in NSHD. Mean walking
speed ranged from 34.4  5.5 SD m/min for get up and go
test in HCS to 74.1  15.9 SD m/min for the 2.4 m walk test in
Whitehall II. For standing balance, the cut-point times for the
bottom 20% ranged from 3.7 s in CaPS to 9.1 s in NSHD. Mean
grip strength for females ranged from 22.1  6.3 SD kg in
LASA to 27.0  7.3 SD kg in NSHD and for males from
35.9  9.0 SD kg in LASA to 45.9  10.9 SD kg in NSHD.
3.1. Meta-analyses
Total sample size in the age and sex-adjusted models varied
between 2146 and 8448 depending on the meta-analysis
(Table 2). Statistically significant summary estimates
between the cortisol measures and physical performance
from fixed or random effects meta-analyses were as follows:
(a) Walking speed — higher morning cortisol (Fig. 1A), larger
diurnal drop (Fig. 1B) and bigger cortisol awakening response
were associated with faster walking speed whilst higher night
time cortisol was associated with slower speed in the age and
gender adjusted models (all p-values < 0.05). After further
adjustment for smoking and BMI only the association with
morning levels was attenuated; the diurnal drop showed the
strongest effect with walking speed. (b) Chair rises — higher
morning cortisol, larger diurnal drop and lower night time
cortisol were associated with quicker chair rise time (note
that a positive coefficient indicates worse performance). No
association was found with cortisol awakening response, but
this result was based on only one study (NSHD). After full
adjustment only the association between larger diurnal drop
and chair rises was unlikely to be due to chance. (c) Standing
balance — only a high night time value was associated with
worse balance and this association persisted after adjust-
ment for obesity and smoking. There was a suggestive age,
sex, BMI and smoking status adjusted association between
higher morning cortisol value and better balance ( p = 0.06).
(d) Grip strength — no association was observed between
cortisol measures and grip strength (see Supplementary Fig-
ures for remaining forest plots).
3.2. Heterogeneity and sub-group analyses
There was evidence of heterogeneity between studies in age
and sex-adjusted meta-analyses of night time cortisol and
walking speed (I2 = 63.6%, p = 0.04). In stratified meta-ana-
lyses, there was no clear evidence that the associations
between the various cortisol measures and physical perfor-
mance differed by age (above and below the median), obe-
sity (obese or non-obese) or gender. There was weak
evidence to suggest that the associations were stronger in
non-obese than obese participants for morning cortisol and
walking speed but this could have been due to chance ( p
(heterogeneity) = 0.10).
3.3. Sensitivity analyses
We found little effect on the meta-analyses for a wide range
of sensitivity analyses (see Supplemental Data 2).
4. Discussion
The results of these meta-analyses showed that more
dynamic activity of the HPA axis, i.e. greater decline, was
associated with better physical performance for most of our
outcomes, and that there were no interactions with age,
gender or BMI. The size of the diurnal decline of cortisol was
the strongest correlate of physical performance. Interest-
ingly, all the measures of HPA dynamic activity including
higher morning cortisol, lower night time cortisol, greater
diurnal drop and increased CAR were all predictive of walking
speed although these associations were attenuated to vary-
ing degrees after adjustment for smoking and BMI.
A lack of diurnal decline has previously been shown to be
associated with increased psychosocial stress (Adam et al.,
2006) and a higher BMI (also shown in the current study — data
not presented). In WHII (Kumari et al., 2009, 2010), indivi-
duals with less diurnal variability had shorter sleep duration
and lower sleep quality. The health consequences of a higher
morning cortisol are less clear. Some have argued that higher
levels may be detrimental and would be associated with
adverse outcomes due to increased cortisol exposure. On
the other hand, higher morning levels may indicate a more
reactive and hence ‘‘healthier’’ HPA axis which should be
associated with better health outcomes. We have previously
observed in the CaPS (Gardner et al., 2011) that higher
morning cortisol was associated with better physical perfor-
mance, suggesting that the latter explanation may be more
valid. The data from this amalgamation of ageing cohorts
supports this assertion whereby the ability to demonstrate a
good waking response was associated with better perfor-
mance. Similarly, CAR is larger in healthy individuals
(Kudielka and Kirschbaum, 2003) and it has been argued that
CAR is an adaptive ‘‘boost’’ response enabling the body to
deal with the stresses of the upcoming day (Adam et al.,
2006). Thus the observed morning response is complex to
interpret as it could reflect the composite effects of
increased stress stimulating the HPA axis which could be
associated with worse outcomes but this may be counter-
balanced by the responsiveness of the HPA axis to a stressor
which may be associated with better outcomes.
We failed to find any convincing evidence that any of our
cortisol parameters were predictive of grip strength. This is
inconsistent with the hypothesis that hypercortisolaemia, as
part of the ageing process, may be associated with general-
ised sarcopenia, but is consistent with the effects seen in
Cushing’s syndrome where proximal muscle weakness is
detected in 56—90% of patients (Fernandez-Rodriguez
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et al., 2009). We should be cautious before concluding a null
association with grip strength: the LASA study found no
associations between morning or night time cortisol and grip
strength cross-sectionally, but did find that higher cortisol
was associated with loss of grip strength over a 4-year period
(Peeters et al., 2008). Grip strength is a simple isometric test
of upper body strength (Kuh et al., 2005) as compared to
walking, chair rising and standing balance which require
strength, balance, postural and motor control (Cooper
et al., 2010). The dynamic measures of walking speed and
chair rising require neuromuscular speed and control (Kuh
et al., 2005) and are distinct from balance in that they also
require leg muscle power (force  velocity, the ability to
generate force quickly) (Peeters et al., 2007). Glucocorticoid
mediated steroid myopathy mainly results in type II (fast
twitch) fibre atrophy (Fernandez-Rodriguez et al., 2009)
which are more efficient for short bursts of speed and power,
such as those required for the get up and go or chair rise time
tests. These mechanisms may contribute to the stronger
associations with walking speed and chair rises than with
balance.
We decided to adjust our associations for BMI as a measure
of adiposity but whether adiposity is secondary to a less
dynamic HPA axis (Bjorntorp, 2001) or vice versa is still
unclear (Fernandez-Rodriguez et al., 2009). Obese indivi-
duals may have reduced cortisone to cortisol conversion
through the expression of 11bHSD1 (Stewart et al., 1999)
and this contributes to their lower morning levels and
reduced diurnal decline. This may be further accentuated
by visceral and subcutaneous adipose tissue 11bHSD1 which
shows different circadian rhythmicity with subcutaneous
adipose tissue reaching peak gene expression at around
8 am and visceral adipose tissue at around 11 pm (Garaulet
et al., 2011). Our BMI-adjusted analyses may be over
adjusted if BMI acts as an intermediary in the pathway
between cortisol and performance. However, we still
observed associations after adjustment though a better
measure of visceral adiposity from DEXA imaging may have
further attenuated the associations.
A key question is whether the HPA axis is driving physical
decline, assuming that our performance measures are rea-
sonable indicators, or whether it is another ageing-related
factor impacting on both the HPA axis and physical perfor-
mance whereby biological ageing drives decline in multiple
systems. The associations between cortisol and physical
performance in the current study are cross-sectional, hence
reverse causation cannot be ruled out. However, similar
associations were found prospectively in CaPS when we
examined the association between repeat cortisol measures
over 20 years and physical performance measures in later life
(Gardner et al., 2011).
4.1. Strengths and limitations
This is the largest pooled study that has ever looked into the
association between cortisol and physical performance and
includes new unpublished data from three relatively large
studies (Boyd Orr, HCS and NSHD). We undertook an IPD meta-
analysis (Riley et al., 2010) which allowed us to standardise
analyses in exactly the same way as well as undertake sub-
group analyses. A further strength of the study was that we
were able to include several objective measures of physical
performance from different population-based cohorts. How-
ever, we may have still been underpowered for some mea-
sures e.g. CAR and for the sub-group analyses and this may
have also explained why we did not find many factors which
explained the heterogeneity of effect. Possible sources of
heterogeneity include the differences in the protocols for
assessment of physical performance which might have biased
the associations. To overcome such differences we standar-
dised the regression coefficients and dichotomised balance
time to make comparisons across cohorts possible, but this
may have diluted some effects as we did not examine abso-
lute but rather relative effects. Furthermore, we have under-
taken sensitivity analysis using the 3 m walk test in HCS
rather than the TUG test and found little effect on the
associations. Indeed, other studies (Birnie et al., 2011;
Cooper et al., 2011a) have shown that it is possible to
combine results from TUG and walking speed tests. Moreover,
when more than one trial was performed (Cooper et al.,
2011a) it was shown that there was little difference to the
findings when analyses were repeated using individual trial,
average and best measures.
Finally, there is measurement error in characterising the
HPA axis, particularly for those studies that used single serum
cortisol measures. Indeed, it has been recommended that the
CAR be performed at least twice on two separate days
(Hellhammer et al., 2007). The inter-assay coefficient of
variation for the salivary cortisol measurements in LASA
was high. Assuming random error, this misclassification of
true cortisol levels would result in an under-estimation of the
true association. More dynamic test such as psychosocial
stressors (Kirschbaum et al., 1993) may give more valid
results but are difficult to include in large population-based
studies.
In conclusion, a more dynamic HPA axis, best measured by
diurnal decline, is associated with better physical perfor-
mance in later life. This may reflect a causal effect of the HPA
axis on physical decline or that other ageing-related factors
are associated with both reduced HPA reactivity and physical
performance. We would recommend that future studies try to
collect both morning and night time samples, preferably for
several days. We do not think that these associations are
driven solely by increased adiposity, though studies with
better measures of adiposity would be helpful. In addition,
data on sleep quality and duration would allow one to test
whether this is a confounding factor (Kumari et al., 2009,
2010).
If the observed associations are causal, diurnal cortisol
profile might provide a surrogate intermediary or secondary
measures for intervention studies (e.g. weight loss or exer-
cise programmes). Furthermore, diurnal cortisol measures,
along with other biological parameters might be used to
develop a frailty index (Varadhan et al., 2008) to target
interventions to high risk individuals. Further follow-up of
these cohorts will enable us to test how cortisol responsive-
ness changes with age and its predictive effect on ageing
traits.
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